Phaxiam: EPIC Bpifrance exceeds 25% of share capital
The public financial institution informed the AMF that it held, directly and indirectly, 2,517,418 Phaxiam shares representing the same number of voting rights, i.e. 25.22% of the capital and 24.84% of the voting rights of this biopharmaceutical company.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction